We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

79 hedge funds and large institutions have $211M invested in Clearside Biomedical in 2018 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 28 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 9

246% more call options, than puts

Call options by funds: $1.04M | Put options by funds: $301K

211% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 9

144% more capital invested

Capital invested by funds: $86.3M → $211M (+$124M)

46% more funds holding

Funds holding: 54 → 79 (+25)

0.86% more ownership

Funds ownership: 3.24% → 4.1% (+0.86%)

Holders
79
Holders Change
+25
Holders Change %
+46.3%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
28
Reduced
9
Closed
9
Calls
$1.04M
Puts
$301K
Net Calls
+$739K
Net Calls Change
+$739K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$13.5M
2
RCM
RA Capital Management
Massachusetts
+$12.4M
3
Millennium Management
Millennium Management
New York
+$11.1M
4
MWNA
Marshall Wace North America
New York
+$5.21M
5
SFM
Sphera Funds Management
Israel
+$4.71M

Top Sellers

Rank Fund Capital Flow
1
HIM
Hillhouse Investment Management
Cayman Islands
-$6.61M
2
First Manhattan
First Manhattan
New York
-$1.42M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.42M
4
CAM
Cormorant Asset Management
Massachusetts
-$487K
5
WS
Wedbush Securities
California
-$342K
Name Holding Trade Value Shares
Change 		Change in
Stake
UOC
26
UBS O'Connor
Illinois
$1.06M +$802K +6,583 New
EGI
27
EAM Global Investors
California
$903K +$684K +5,613 New
KCM
28
Kornitzer Capital Management
Kansas
$805K – – –
Ameriprise
29
Ameriprise
Minnesota
$782K +$591K +4,853 New
PPA
30
Parametric Portfolio Associates
Washington
$726K +$549K +4,509 New
PVI
31
Pura Vida Investments
New York
$725K +$549K +4,507 New
TCIM
32
TIAA CREF Investment Management
New York
$695K +$55.1K +452 +12%
Morgan Stanley
33
Morgan Stanley
New York
$582K +$18.2K +149 +4%
Goldman Sachs
34
Goldman Sachs
New York
$507K -$1.46K -12 -0.4%
DZ Bank
35
DZ Bank
Germany
$483K +$365K +3,000 New
TA
36
Teachers Advisors
New York
$431K – – –
Charles Schwab
37
Charles Schwab
California
$415K – – –
SI
38
Sofinnova Investments
California
$380K +$287K +2,359 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$343K -$5.12K -42 -2%
EMG
40
Ellington Management Group
Connecticut
$338K +$256K +2,100 New
Deutsche Bank
41
Deutsche Bank
Germany
$301K -$157K -1,290 -41%
FPC
42
Falcon Point Capital
California
$265K +$731 +6 +0.4%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$237K – – –
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$228K +$173K +1,417 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$200K +$8.04K +66 +6%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$183K +$100K +821 +261%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$161K – – –
DS
48
DRW Securities
Illinois
$161K +$122K +1,000 New
State Board of Administration of Florida Retirement System
49
State Board of Administration of Florida Retirement System
Florida
$156K – – –
BFM
50
Boothbay Fund Management
New York
$156K +$118K +966 New
1
2
3 4

CLSD Hedge Fund Activity: Q1 2018 in Review

79 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q1 2018, worth a combined $211M — up 144% from $86.3M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CLSD positions and 9 closed out — a net gain of 25 holders — while 28 added to existing stakes and 9 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $13.5M. The largest seller was Hillhouse Investment Management, exiting entirely with an estimated $6.61M sold.

  • 79 institutional investors held Clearside Biomedical (CLSD) as of Q1 2018, up from 54 in Q4 2017.
  • Funds reported $211M of Clearside Biomedical stock for Q1 2018, up 144% quarter-over-quarter.
  • 34 funds opened new Clearside Biomedical positions in Q1 2018 and 9 closed out, a net change of +25 holders.
  • The largest Clearside Biomedical buyer in Q1 2018 was Wellington Management Group, an estimated $13.5M added.
  • The largest Clearside Biomedical seller in Q1 2018 was Hillhouse Investment Management, an estimated $6.61M sold.

Based on aggregated 13F filings for Q1 2018.